The Aerogen Ultra offers superior drug delivery and improved patient response in the Emergency Department.

  • Significantly more more medication in half the time1
  • Improved patient response2
  • Quick & east to set-up with no added flow
  • Virually silent operation

Clinical evidence³

New clinical outcome data demonstrates how Aerogen Ultra is transforming the treatment of patients in the Emergency Department

Study Design

A retrospective chart review of 1,594 patients at St. John Hospital and Medical Center, Detroit compared clinical outcomes associated with the use of a hospital standard small volume nebuliser (SVN) versus the Aerogen Ultra.

Download Study Paper
median reduction in ED length
of stay
in admission
achieved symptom control with 2.5mg
higher discharge

Aerogen Ultra delivers 6X greater lung dose*

Aerogen Ultra

Jet Nebuliser


Lung dose delivered: Aerogen Ultra 34.1%; Jet Nebuliser 5.2% (p < 0.001)
Residual dose volume: Aerogen Ultra 2.4%; Jet Nebuliser 62.8% (p = 0.008)

Nebulisers were filled with diethylenetriaminepentaacetic acid labelled with
technetium-99 m (99mTc-DTPA, 2 mCi/4 mL) Dugernier J. et al 20174

*Aerogen Ultra compared to a standard Jet Nebuliser.


Our unique palladium vibrating mesh technology, Aerogen Vibronic® is a breakthrough in aerosol drug delivery and is at the heart of all our products.

The central aperture plate is just 5mm in diameter and is perforated with 1000 precision formed holes, that vibrate at 128,000 times per second, to produce the optimum particle size for deep lung penetration.

Find out more


1. Hickin S, Mac Loughlin R, Sweeney L, Tatham A and Gidwani S. Poster at the College of Emergency Medicine Clinical Excellence Conference. 2014. 2.Cushen B, Alsaid A, Abdulkareem A and Costello RW. ITS poster presentation. 2016. 3. Dunne RB and Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. The American journal of emergency medicine. 2017